ALKS Alkermes plc.
2026Q1 · CUSIP G01767105 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
384
Δ holders QoQ
+19
Breadth percentile
Top 16%
Whale holders
180
Δ whales
+1
Inst. holding value
$6.0B
New positions
74
Closed positions
55
Price momentum (1Q)
—
Put / Call
7/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 12 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 16% | — | — |
| 2025Q1 | Top 8% | — | — |
| 2024Q1 | Top 8% | — | — |
| 2023Q3 | Top 13% | — | — |
| 2023Q2 | Top 7% | — | — |
| 2022Q2 | Top 3% | — | — |
| 2022Q1 | Top 5% | — | — |
| 2021Q2 | Top 10% | — | — |
Options Sentiment
Put holders
7
QoQ: +1
Call holders
6
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
58.6
EPS (TTM)
$0.90
EPS YoY
-56.9%
Revenue (TTM)
$1.6B
Revenue YoY
+3.2%
Net margin
9.8%
ROE
8.7%
Debt ratio
58.9%
FCF (TTM)
$222M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.